Latest Insider Transactions at Derm Tech, Inc. (DMTK)
This section provides a real-time view of insider transactions for Derm Tech, Inc. (DMTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DermTech, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DermTech, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 29
2021
|
Burkhard Jansen Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,897
+5.45%
|
-
|
Mar 29
2021
|
Kevin M Sun Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,020
+4.79%
|
-
|
Mar 29
2021
|
Todd Michael Wood Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,162
+4.51%
|
-
|
Mar 18
2021
|
John Dobak Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,150
-1.32%
|
$378,950
$53.35 P/Share
|
Mar 08
2021
|
John Dobak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
780
-0.14%
|
$39,000
$50.04 P/Share
|
Mar 08
2021
|
Claudia Ibarra Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,431
-2.07%
|
$121,550
$50.04 P/Share
|
Mar 08
2021
|
Kevin M Sun Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,886
-1.87%
|
$144,300
$50.04 P/Share
|
Mar 08
2021
|
Todd Michael Wood Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
417
-0.25%
|
$20,850
$50.04 P/Share
|
Jan 26
2021
|
Rtw Investments, LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
31,450
+1.0%
|
$283,050
$9.54 P/Share
|
Jan 26
2021
|
Burkhard Jansen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.95%
|
$30,000
$6.94 P/Share
|
Jan 11
2021
|
Matthew L. Posard Director |
BUY
Open market or private purchase
|
Direct |
33,898
+28.07%
|
$983,042
$29.5 P/Share
|
Jan 07
2021
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+6.08%
|
$5,800,000
$29.5 P/Share
|
Jan 05
2021
|
Ramin Akhavan General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
36,250
+31.06%
|
-
|
Dec 14
2020
|
Burkhard Jansen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.95%
|
$60,000
$12.41 P/Share
|
Dec 14
2020
|
Scott R Pancoast Director |
SELL
Open market or private sale
|
Direct |
6,000
-11.97%
|
$78,000
$13.93 P/Share
|
Dec 11
2020
|
Burkhard Jansen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.33%
|
$60,000
$12.2 P/Share
|
Dec 08
2020
|
John Dobak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
786
-0.14%
|
$8,646
$11.86 P/Share
|
Dec 08
2020
|
Claudia Ibarra Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,421
-2.06%
|
$26,631
$11.86 P/Share
|
Dec 08
2020
|
Todd Michael Wood Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
428
-0.26%
|
$4,708
$11.86 P/Share
|
Dec 07
2020
|
Scott R Pancoast Director |
SELL
Open market or private sale
|
Direct |
2,382
-4.54%
|
$28,584
$12.0 P/Share
|
Oct 26
2020
|
Gary E. Jacobs Director |
BUY
Exercise of conversion of derivative security
|
Direct |
692
+0.13%
|
$692
$1.08 P/Share
|
Aug 17
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
31,450
+1.08%
|
$283,050
$9.54 P/Share
|
May 27
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
228,498
+7.41%
|
-
|
Apr 01
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
26,539
+1.0%
|
$265,390
$10.41 P/Share
|
Mar 31
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.19%
|
$55,000
$11.26 P/Share
|
Mar 05
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
23,955
+0.91%
|
$335,370
$14.61 P/Share
|
Mar 04
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,447
+0.17%
|
$62,258
$14.75 P/Share
|
Mar 03
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
13,000
+0.5%
|
$182,000
$14.52 P/Share
|
Mar 02
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,000
+0.58%
|
$180,000
$12.83 P/Share
|
Feb 28
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
152,456
+5.66%
|
$1,524,560
$10.5 P/Share
|
Jul 22
2019
|
Cowen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
300
-0.02%
|
$3,000
$10.37 P/Share
|
Jun 28
2019
|
Cowen Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100
+0.02%
|
$1,000
$10.4 P/Share
|
Jun 27
2019
|
Cowen Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200
+0.03%
|
$2,000
$10.38 P/Share
|
Jun 04
2019
|
Cowen Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,100
+0.09%
|
$11,000
$10.37 P/Share
|
May 31
2019
|
Cowen Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,500
+0.24%
|
$15,000
$10.34 P/Share
|
May 30
2019
|
Cowen Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100
+0.02%
|
$1,000
$10.34 P/Share
|
Apr 30
2019
|
Cowen Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,262
+0.37%
|
$92,620
$10.29 P/Share
|
Mar 29
2019
|
Cowen Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100
+0.02%
|
$1,000
$10.32 P/Share
|
Mar 21
2019
|
Polar Asset Management Partners Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,144,759
-100.0%
|
$31,447,590
$10.35 P/Share
|